@article{0d5057e93de44bba9ec2c17a280fccd0,
title = "Methotrexate for inflammatory bowel disease: time for reconsideration",
keywords = "Anti-Inflammatory Agents/adverse effects, Biological Products/therapeutic use, Clinical Decision-Making, Colitis, Ulcerative/diagnosis, Combined Modality Therapy, Crohn Disease/diagnosis, Evidence-Based Medicine, Gastrointestinal Agents/adverse effects, Humans, Methotrexate/adverse effects, Patient Selection, Remission Induction, Treatment Outcome",
author = "Nielsen, {Ole Haagen} and Ainsworth, {Mark Andrew} and Casper Steenholdt",
year = "2019",
month = may,
doi = "10.1080/17474124.2019.1596797",
language = "English",
volume = "13",
pages = "407--409",
journal = "Expert Review of Gastroenterology & Hepatology",
issn = "1747-4124",
publisher = "Expert Reviews Ltd",
number = "5",
}